[OP.4C.02] CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY. THE DENERVHTA STUDY RESULTS | Publicación